SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-017696
Filing Date
2020-09-14
Accepted
2020-09-14 09:00:22
Documents
13
Period of Report
2020-09-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37098
2 ex10-1.htm EX-10.1 66190
  Complete submission text file 0001493152-20-017696.txt   289605

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lctx-20200911.xsd EX-101.SCH 3195
4 XBRL LABEL FILE lctx-20200911_lab.xml EX-101.LAB 34591
5 XBRL PRESENTATION FILE lctx-20200911_pre.xml EX-101.PRE 22716
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3603
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12830 | Film No.: 201172394
SIC: 2836 Biological Products, (No Diagnostic Substances)